Estradiol enantate

Estradiol enantate (EE), also spelled estradiol enanthate, is a form of estrogen used in hormone therapy for menopausal symptoms and in hormonal contraception. It is a long-acting ester of estradiol, the primary female sex hormone, and is administered via intramuscular injection.

Medical Uses

Estradiol enantate is primarily used in hormone replacement therapy (HRT) for menopausal symptoms such as hot flashes, vaginal atrophy, and osteoporosis. It is also used in contraception in combination with a progestogen. The medication provides a long-term release of estradiol, making it a convenient option for individuals seeking sustained hormone levels.

Pharmacology

Pharmacodynamics

As an estrogen, estradiol enantate binds to and activates the estrogen receptor (ER), leading to the regulation of gene transcription and expression in estrogen-responsive tissues. This action is responsible for its effects on the reproductive system, bone density, and the maintenance of secondary sexual characteristics.

Pharmacokinetics

Following intramuscular injection, estradiol enantate is slowly absorbed into the bloodstream, providing a prolonged duration of action. This allows for less frequent dosing schedules compared to other forms of estrogen therapy. The ester is eventually hydrolyzed, releasing estradiol, which is then metabolized in the liver and excreted in urine and feces.

Adverse Effects

The use of estradiol enantate can lead to side effects similar to those of other estrogen therapies, including nausea, breast tenderness, headache, and an increased risk of thromboembolic events. Long-term use may also be associated with an increased risk of breast cancer and endometrial cancer, although the risk varies depending on whether a progestogen is used in combination with estradiol enantate.

Contraindications

Estradiol enantate is contraindicated in individuals with known hypersensitivity to the drug, those with a history of estrogen-dependent tumors, active or recent thromboembolic disease, and unexplained vaginal bleeding. It should also be used with caution in patients with liver dysfunction, gallbladder disease, and in those with a history of depression.

Interactions

Estradiol enantate may interact with various medications, including cytochrome P450 substrates, anticoagulants, and thyroid hormone replacement therapy. It is important to consult a healthcare provider for a complete list of potential interactions.

Pharmaceutical Information

Estradiol enantate is available in various formulations and dosages for intramuscular injection. The choice of dosage and frequency of administration should be individualized based on the patient's needs and response to therapy.

Society and Culture

Estradiol enantate has been used in medical practice for several decades and is included in some formulations of combined injectable contraceptives. Its role in hormone therapy for transgender individuals is also recognized, although specific guidelines may vary.

See Also

• Estrogen
• Hormone replacement therapy
• Contraception
• Estrogen receptor

• 

  Estradiol enanthate

• 

  Estradiol enanthate molecule ball

• 

  Estradiol

• 

  Estradiol levels after an intramuscular injection of different doses of estradiol enanthate in premenopausal women

• 

  Estradiol levels after a single intramuscular injection of 10 mg estradiol enantate in postmenopausal women

• 

  Estradiol and prolactin levels after the last injection during therapy with estradiol enantate and dihydroxyprogesterone acetophenide in women

• 

  Estradiol levels with estradiol enanthate and dihydroxyprogesterone acetophenide after single or repeated injections in premenopausal women

• 

  Idealized curves of estradiol levels after injection of different estradiol esters in women

• 

  Estradiol enanthate availability